Compounds > losartan

losartan and physostigmine

losartan has been researched along with physostigmine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Barnes, JC; Dennes, RP1
Chopra, K; Kulkarni, SK; Raghavendra, V1
Endo, S; Fukumori, R; Hagiwara, Y; Kubo, T1
Hagiwara, Y; Kubo, T; Ohi, M1

Reviews

1 review(s) available for losartan and physostigmine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

9 other study(ies) available for losartan and physostigmine

ArticleYear
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Psychopharmacology, 1993, Volume: 111, Issue:4

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bridged Bicyclo Compounds; Cholinergic Agents; Dose-Response Relationship, Drug; Imidazoles; Injections, Intraventricular; Losartan; Male; Maze Learning; Memory; Memory, Short-Term; N-Methylscopolamine; Parasympatholytics; Physostigmine; Pilocarpine; Rats; Scopolamine; Scopolamine Derivatives; Space Perception; Spiro Compounds; Tetrazoles

1993
Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory.
    Neuropeptides, 1998, Volume: 32, Issue:5

    Topics: Angiotensin Receptor Antagonists; Animals; Avoidance Learning; Cholinergic Agents; Cholinesterase Inhibitors; Female; Losartan; Male; Maze Learning; Memory, Short-Term; Mice; Mice, Inbred BALB C; Motor Activity; Muscarinic Antagonists; Nootropic Agents; Physostigmine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Scopolamine; Space Perception

1998
Activation of hypothalamic angiotensin receptors produces pressor responses via cholinergic inputs to the rostral ventrolateral medulla in normotensive and hypertensive rats.
    Brain research, 2002, Oct-25, Volume: 953, Issue:1-2

    Topics: Acetylcholine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Carbachol; Cholinergic Agonists; Cholinergic Fibers; Cholinesterase Inhibitors; Electric Stimulation; gamma-Aminobutyric Acid; Hypertension; Hypothalamus, Anterior; Iontophoresis; Losartan; Male; Medulla Oblongata; Microinjections; Muscarinic Antagonists; Neural Pathways; Physostigmine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Scopolamine; Vasoconstrictor Agents

2002
Cholinergic stimulation in the posterior hypothalamic nucleus activates angiotensin II-sensitive neurons in the anterior hypothalamic area of rats.
    Brain research bulletin, 2005, Oct-15, Volume: 67, Issue:3

    Topics: Acetylcholine; Action Potentials; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anterior Hypothalamic Nucleus; Carbachol; Cholinergic Agonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hypothalamus, Posterior; Losartan; Male; Microinjections; Muscarinic Antagonists; Neurons; Physostigmine; Rats; Rats, Wistar; Scopolamine; Time Factors

2005